ARM’s Q3 2020 Trend Talk
Global financing for the regenerative medicine sector set an annual record of $15.9 billion through just the first three quarters of 2020, according to data released by ARM. Despite the COVID-19 pandemic, financing for the cell, gene, and tissue-based therapies sector surpassed the previous record of $13.5 billion set during full-year 2018.
